Literature DB >> 28011494

mMRI at 3.0 T as an Evaluation Tool of Therapeutic Response to Neoadjuvant CRT in Patients with Advanced-stage Rectal Cancer.

Ulrike I Attenberger1, Melissa M Ong1, Nils Rathmann1, Fabian Doyon2, Peter Kienle2, Ralf-Dieter Hofheinz3, Lothar R Pilz4, Dietmar J Dinter1, Stefan O Schoenberg1, Daniel Hausmann5.   

Abstract

AIM: To assess whether multiparametric MRI (mMRI) can serve as a tool for evaluating response to chemoradiation therapy (CRT) in advanced-stage rectal cancer. PATIENTS AND METHODS: Twenty-one patients underwent a mMRI protocol at 3T before and after CRT. Two experienced radiologists evaluated the MRI measurements and inter-reader correlation was assessed. Changes in functional parameters in relation to regression, as well as pT stage were analyzed. The perfusion parameters plasma flow (PF) and mean transit time (MTT) were calculated offline using the established UMM Perfusion tool.
RESULTS: Apparent diffusion coefficient values were significantly different among the different tumor RGs before CRT (p=0.041). Changes of dynamic contrast enhanced (DCE) MRI values did not reflect treatment response (PF: p=0.5; MTT: p=0.74).
CONCLUSION: The results of our study population indicate that a high initial apparent diffusion coefficient value may be predictive of response to therapy following CRT. Copyright
© 2017 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Multi-parametric MRI; apparent diffusion coefficient; dynamic contrast enhancement; rectal cancer

Mesh:

Year:  2017        PMID: 28011494     DOI: 10.21873/anticanres.11309

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Multiparametric MRI of rectal cancer-repeatability of quantitative data: a feasibility study.

Authors:  Bengi Gürses; Emre Altınmakas; Medine Böge; M Serhat Aygün; Onur Bayram; Emre Balık
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

Review 2.  Multiparametric MRI in rectal cancer.

Authors:  Bengi Gürses; Medine Böge; Emre Altınmakas; Emre Balık
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

Review 3.  Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?

Authors:  Ruben S A Goedegebuure; Leonie K de Klerk; Adam J Bass; Sarah Derks; Victor L J L Thijssen
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

4.  Are We There Yet? The Value of Deep Learning in a Multicenter Setting for Response Prediction of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy.

Authors:  Barbara D Wichtmann; Steffen Albert; Wenzhao Zhao; Angelika Maurer; Claus Rödel; Ralf-Dieter Hofheinz; Jürgen Hesser; Frank G Zöllner; Ulrike I Attenberger
Journal:  Diagnostics (Basel)       Date:  2022-06-30

5.  Variability and Reproducibility of 3rd-generation dual-source dynamic volume perfusion CT Parameters in Comparison to MR-perfusion Parameters in Rectal Cancer.

Authors:  Sonja Sudarski; Thomas Henzler; Teresa Floss; Tanja Gaa; Mathias Meyer; Holger Haubenreisser; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.